Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Teh Seng Pharmaceutical Manufacturing is a Taiwan-based pharmaceutical manufacturer focused on topical and transdermal drug delivery products, including pain-relief patches, transdermal patches, oral and sublingual films, and related external preparations. The company also operates as a CDMO for topical dosage forms and drug-delivery systems, and has expanded into biocellulose masks, cosmeceutical patches, and biotechnology-based skincare products. Founded in 1975 in Tainan, Teh Seng appears to be a long-standing commercial-stage business with PIC/S GMP-compliant manufacturing and regulatory exposure that includes inspections or audits by agencies such as the US FDA and other international authorities. It serves markets in Taiwan and overseas and is listed in Taiwan under stock code 7860. The company is best characterized as a specialty manufacturer and drug-delivery company rather than a clinical-stage biotech innovator with a disclosed therapeutic pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Teh Seng Pharmaceutical Manufacturing.